Waiting
Login processing...

Trial ends in Request Full Access Tell Your Colleague About Jove
Journal / Cancer Research / Profiling der Sensitivität gegenüber…
JoVE Journal
Cancer Research

This content is Free Access.

JoVE Journal Cancer Research
Profiling der Sensitivität gegenüber zielgerichteten Therapien in EGFR-mutierten NSCLC-patientenabgeleiteten Organoiden
Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2
Journal (Cancer Research)
Three Differential Expression Analysis Methods for RNA Sequencing: limma, EdgeR, DESeq2
Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
Journal (Cancer Research)
Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
 
Click here for the English version

Profiling der Sensitivität gegenüber zielgerichteten Therapien in EGFR-mutierten NSCLC-patientenabgeleiteten Organoiden

Article DOI: 10.3791/63039-v • 08:52 min • November 22nd, 2021
November 22nd, 2021 •
1,2,3, 1,2, 1,2,3, 1,2,3
1Department of Medicine, University of California, San Francisco, 2Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, 3Department of Cellular and Molecular Pharmacology, University of California, San Francisco

Chapters

Summary
Automatic Translation

Please note that all translations are automatically generated.

Click here for the English version.

Dieses Protokoll beschreibt eine standardisierte Bewertung von Arzneimittelsensitivitäten gegenüber zielgerichteten Signalinhibitoren in NSCLC-patientenabgeleiteten Organoidmodellen.

Tags

Krebsforschung Ausgabe 177 Organoid Lungenorganoid PDO NSCLC Lungenkrebs Osimertinib EGFR gezielter Inhibitor Resistenz
Read Article

Get cutting-edge science videos from JoVE sent straight to your inbox every month.

Waiting X
Simple Hit Counter